ACER Acer Therapeutics Inc.

Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  14,310,244
Average volume:  81,439
Market cap:   $31,482,537
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00444P108
ISIN:        US00444P1084
Valuation   (See tab for details)
PE ratio:   -20.05
PB ratio:   14.04
PS ratio:   7.87
Return on equity:   -658.42%
Net income %:   -356.44%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy